Vascular Endothelial Growth Factor/Placental Growth Factor Heterodimer Levels in Preterm Infants with Bronchopulmonary Dysplasia

被引:18
|
作者
Procianoy, Renato S. [1 ,2 ]
Hentges, Claudia R. [1 ,2 ]
Silveira, Rita C. [1 ,2 ]
机构
[1] Univ Fed Rio Grande do Sul, Dept Pediat, Porto Alegre, RS, Brazil
[2] Hosp Clin Porto Alegre, Newborn Sect, Porto Alegre, RS, Brazil
关键词
preterm neonates; VEGF/PIGF heterodimer; angiogenesis; respiratory distress syndrome; bronchopulmonary dysplasia; CHRONIC LUNG-DISEASE; PREMATURE-INFANTS; ANGIOGENESIS; VEGF; ASTHMA; PREECLAMPSIA; RECEPTOR-1; EXPRESSION; DISCOVERY;
D O I
10.1055/s-0035-1566294
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background Bronchopulmonary dysplasia (BPD) is associated with changes in pulmonary angiogenesis. However, the role of the vascular endothelial growth factor/placental growth factor (VEGF/PIGF) heterodimer, an antiangiogenic factor, remains unknown in this disease. Objective To compare VEGF/PIGF levels in preterm infants with and without BPD. Methods This study was approved by the Institutional Review Board. Preterm neonates with birth weight <2,000 g and gestational age <= 34 weeks were included. Exclusion criteria were: neonates transferred from other institutions after 72 hours of life; death before blood collection; presence of major congenital malformations, inborn errors of metabolism, and early sepsis; and mothers with multiple pregnancies, TORCH infections, HIV infection, or autoimmune diseases. BPD was defined as the need for oxygen therapy for a period equal to or greater than 28 days, accompanied by radiographic changes compatible with the disease. Blood was collected from neonates in the first 72 hours of life. VEGF/PIGF levels were measured using the enzyme-linked immunosorbent assay method. The chi-square test, t-test, Mann Whitney test, analysis of variance, and Kruskal Wallis test were used for statistical analysis. Variables found to be significant in the univariate analysis were included in the multivariate analysis. Results Seventy-three patients were included (19 with BPD, 43 without BPD, and 11 neonates who died in the first 28 days of life), with a mean (SD) gestational age of 30.32 (2.88) weeks and birth weight of 1,288 (462) g. Median VEGF/PIGF levels were higher in the groups with BPD and death in the first 28 days of life than in the group without BPD (16.46 [IQR, 12.19-44.57] and 20.64 [IQR, 13.39-50.22], respectively, vs. 9.14 [IQR, 0.02-20.64] pg/mL], p < 0.001). Higher VEGF/P1GF levels remained associated with BPD and death in the first 28 days of life in the multivariate analysis. Conclusion Higher plasma VEGF/PIGF levels were found in preterm neonates with BPD and in those who died in the first 28 days of life, suggesting an important role of this substance in pulmonary vascular development.
引用
收藏
页码:480 / 485
页数:6
相关论文
共 50 条
  • [41] Placental growth factor and vascular endothelial growth factor receptor-2 in human lung development
    Janer, Joakim
    Andersson, Sture
    Haglund, Caj
    Karikoski, Riitta
    Lassus, Patrik
    PEDIATRICS, 2008, 122 (02) : 340 - 346
  • [42] Vascular endothelial growth factor, as compared with placental growth factor, is increased in severe sepsis but not in organ failure
    Smadja, D. M.
    Borgel, D.
    Diehl, J. -L.
    Gaussem, P.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2012, 10 (05) : 974 - 976
  • [43] Effects of endostatin, placental growth factor and vascular endothelial growth factor on blood retinal barrier function
    Brankin, B
    Stitt, AW
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 : U404 - U404
  • [44] Upregulation of placental growth factor by vascular endothelial growth factor via a post-transcriptional mechanism
    Yao, YG
    Yang, HS
    Cao, ZM
    Danielsson, J
    Duh, EJ
    FEBS LETTERS, 2005, 579 (05): : 1227 - 1234
  • [45] PURIFICATION AND CHARACTERIZATION OF A NATURALLY-OCCURRING VASCULAR ENDOTHELIAL GROWTH-FACTOR PLACENTA GROWTH-FACTOR HETERODIMER
    DISALVO, J
    BAYNE, ML
    CONN, G
    KWOK, PW
    TRIVEDI, PG
    SODERMAN, DD
    PALISI, TM
    SULLIVAN, KA
    THOMAS, KA
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (13) : 7717 - 7723
  • [46] Pulmonary vascular endothelial growth factor-C in development and lung injury in preterm infants
    Janer, Joakim
    Lassus, Patrik
    Haglund, Caj
    Paavonen, Karri
    Alitalo, Karl
    Andersson, Sture
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2006, 174 (03) : 326 - 330
  • [47] Vascular endothelial growth factor: Not just an endothelial cell growth factor?
    Roberts, JR
    Perkins, GD
    Thickett, DR
    THORAX, 2005, 60 : II15 - II16
  • [48] Role of vascular endothelial growth factor and vascular endothelial growth factor receptors in vascular development
    Carmeliet, P
    Collen, D
    VASCULAR GROWTH FACTORS AND ANGIOGENESIS, 1999, 237 : 133 - 158
  • [49] Changes in expression of vascular endothelial growth factor D-related genes in placental mesenchymal dysplasia
    Takahashi, Hironori
    Matsubara, Shigeki
    Kuwata, Tomoyuki
    Saruyama, Miyuki
    Usui, Rie
    Ohkuchi, Akihide
    Takizawa, Toshihiro
    Suzuki, Mitsuaki
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2014, 40 (04) : 1145 - 1149
  • [50] Assessment of Vascular Endothelial Growth Factor, Basic Fibroblast Growth Factor, and Transforming Growth Factor Levels in Amniotic Fluid
    Bedaiwy, Mohamed A.
    Burlingame, Janet M.
    Hussein, Mustafa
    Flyckt, Rebecca
    Assad, Radwan
    Falcone, Tommaso
    JOURNAL OF REPRODUCTIVE MEDICINE, 2012, 57 (9-10) : 405 - 410